Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
Krystal Biotech, Inc. (KRYS) had Book Value Per Share of $45.92 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$119.22M |
|
$54.77M |
|
$6.44M |
|
$112.78M |
|
$60.80M |
|
$58.42M |
|
$7.66M |
|
$66.08M |
|
$66.08M |
|
$54.77M |
|
$54.77M |
|
$54.77M |
|
$54.77M |
|
$58.42M |
|
$59.98M |
|
29.53M |
|
30.66M |
|
$1.85 |
|
$1.79 |
|
| Balance Sheet Financials | |
$1.06B |
|
$153.78M |
|
$441.00M |
|
$1.50B |
|
$127.40M |
|
-- |
|
$14.12M |
|
$141.52M |
|
$1.36B |
|
$1.36B |
|
$1.36B |
|
29.60M |
|
| Cash Flow Statement Financials | |
$155.17M |
|
$-225.17M |
|
$4.59M |
|
$496.30M |
|
$427.74M |
|
$-68.56M |
|
$27.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
94.60% |
|
49.00% |
|
49.00% |
|
-- |
|
55.43% |
|
45.94% |
|
$144.46M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.14 |
|
0.86 |
|
104.68 |
|
4.03% |
|
4.03% |
|
3.65% |
|
4.03% |
|
|
Book Value Per Share |
$45.92 |
$4.71 |
|
$5.06 |
|